Disclosures: Rohit Loomba, MD, is a consultant or advisory board member for Aardvark Therapeutics, Altimmune, Anylam/Regeneron, Amgen, Arrowhead Pharmaceuticals, AstraZeneca, Bristol-Myer Squibb, CohBar, Eli Lilly, Galmed, Gilead, Glympse bio, Hightide, Inipharma, Intercept, Inventiva, Ionis, Janssen Inc., Madrigal, Metacrine, Inc., NGM Biopharmaceuticals, Novartis, Novo Nordisk, Merck, Pfizer, Sagimet, Theratechnologies, 89 bio, Terns Pharmaceuticals and Viking Therapeutics
Exendin-based GLP-1RAs, such as exenatide, may have higher immunogenicity
Wegovy coverage for weight management is growing but inconsistent
Complete the Cora Health online health assessment at trycora.io
Research shows that HFCS consumption can trigger metabolic syndrome features, including insulin resistance and visceral fat accumulation, even without notable weight gain Artificial Sweeteners These may have zero calories, but stuff like aspartame or sucralose has an influence on gut bacteria
Additionally, the study was a single-center investigation
